Alzheimer’s Disease
Diagnosis, Molecular Targets, and Therapeutic Modalities
- Publisher's listprice GBP 105.00
-
50 163 Ft (47 775 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 10% (cc. 5 016 Ft off)
- Discounted price 45 147 Ft (42 998 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
50 163 Ft
Availability
Not yet published.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Edition number 1
- Publisher CRC Press
- Date of Publication 17 December 2025
- ISBN 9781032991290
- Binding Hardback
- No. of pages320 pages
- Size 280x210 mm
- Language English
- Illustrations 51 Illustrations, black & white; 2 Halftones, black & white; 49 Line drawings, black & white; 42 Tables, black & white 700
Categories
Short description:
Alzheimer’s disease continues to present one of the foremost scientific and clinical challenges in contemporary neuroscience. Despite significant advances in molecular biology and neuroimaging, its complex etiology and progressive course remain only partially understood, and truly effective disease-modifying therapies remain elusive.
MoreLong description:
Alzheimer’s disease continues to present one of the foremost scientific and clinical challenges in contemporary neuroscience. Despite significant advances in molecular biology and neuroimaging, its complex etiology and progressive course remain only partially understood, and truly effective disease-modifying therapies remain elusive.
This scholarly volume offers a comprehensive and integrative examination of Alzheimer’s disease, combining cutting-edge research with clinical perspectives. Alzheimer’s Disease: Diagnosis, Molecular Targets, and Therapeutic Modalities assembles contributions from leading experts, providing in-depth analysis across a wide range of critical topics:
- Innovative diagnostic biomarkers for early detection, prognosis, and therapeutic monitoring
- Exploration of molecular targets including secretases, SIRT2, RAGE, calpain, caspases, NMDA receptors, and others implicated in AD pathophysiology
- Emerging therapeutic interventions encompassing enzyme inhibitors, immunotherapeutic strategies, metal chelation, neurotrophic modulation, and aggregation inhibitors
- Advances in translational research featuring nanotechnology-based delivery systems and bioactive natural compounds
- Evidence-based lifestyle interventions integrating nutrition and physical activity in disease management
Spanning 21 rigorously curated chapters, this volume offers a multidisciplinary framework that bridges fundamental research, translational applications, and clinical relevance. It is an essential reference for neuroscientists, clinical researchers, pharmacologists, graduate students, and healthcare professionals engaged in the investigation and management of neurodegenerative disorders.
By synthesizing current scientific knowledge with emerging therapeutic strategies, this volume aims to advance understanding and stimulate further research toward effective interventions for Alzheimer’s disease.
MoreTable of Contents:
1. Understanding Alzheimer's Disease: An Introduction, Pathophysiology, and Diagnosis 2. Alzheimer's Disease: The Role of Blood Brain Barrier and Strategy to Cross BBB 3. The Application of Vaccines in Alzheimer's Disease: Active and Passive Immunotherapies 4. Secretase-Related Interventions in Alzheimer's: α, β, γ-Secretase, γ-Secretase Inhibitors (GSIs), γ-Secretase Modulators (GSMs) and Natural Products as GSMs 5. A Potential Modulator in Alzheimer's Disease: SIRT2 Inhibitors 6. Therapeutic Potential of Caspase Inhibitors in Alzheimer's Disease 7. Calpain Inhibitors: A Promising Therapeutic Approach in Alzheimer's Disease 8. Acetylcholinesterase Inhibitors: A Viable Therapeutic Strategy for Alzheimer's Disease 9. Noncompetitive N-Methyl-D-Aspartate (NMDA) Antagonist for Prospective Alzheimer's Disease Treatments 10. Phosphodiesterase Inhibitors: A Promising Avenue for Modulating Cognitive Dysfunction in Alzheimer's Disease 11. Autophagy Enhancer: A Promising Therapeutic Approach for Alzheimer's Treatment 12. Therapeutic Potential of Receptor for Advanced Glycation End-Products (RAGE) Inhibitors in the Treatment of Alzheimer's Disease 13. Targeting Alzheimer's Disease Using Neurotrophic Agents and Mimetics: Current Strategies and Challenges 14. Metal Chelators: A Promising Avenue for the Development of Novel Therapeutics for Alzheimer's Disease 15. Apolipoprotein E Based Treatment Approach for Genetically High-Risk Alzheimer's Patients 16. Biomarkers: Diagnostic, Prognostic and Therapeutic Monitoring of Alzheimer's Disease 17. Non-Peptidic Anti-Aggregate Compounds: A Promising Avenue for Alzheimer's Disease Therapy 18. Translational Potentials of Nanotechnology-Based Interventions for Alzheimer's Disease 19. Target of the Neurodegenerative Diseases and Mechanism of the Potent Natural Molecule 20. Therapeutic Nutrition Strategies in Alzheimer's Disease 21. The Role and Importance of Exercise in Alzheimer's Disease
More
